EC Number   |
Title |
Organism |
|---|
   2.7.11.20 | A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors |
Homo sapiens |
| 2.7.11.20 | Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes |
Mus musculus |
| 2.7.11.20 | Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes |
Rattus norvegicus |
| 2.7.11.20 | Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy |
Homo sapiens |
| 2.7.11.20 | Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy |
Homo sapiens |
| 2.7.11.20 | Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts |
Homo sapiens |
| 2.7.11.20 | Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts |
Rattus norvegicus |
| 2.7.11.20 | Eukaryotic elongation factor 2 kinase (eEF2K) in cancer |
Homo sapiens |
| 2.7.11.20 | Eukaryotic elongation factor 2 kinase a pharmacological target to regulate protein translation dysfunction in neurological diseases |
Mus musculus |
| 2.7.11.20 | Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases |
Homo sapiens |
